Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Peter Molloy has a successful track record of profitably recycling old drugs


Astrazeneca Share News (AZN)

Stock Market news at lse.co.uk - RSS News Feeds

Share News for Astrazeneca (AZN)


Share Price: 4,999.50Bid: 4,999.50Ask: 5,001.00Change: -7.50 (-0.15%)Faller - Astrazeneca
Spread: 1.50Spread as %: 0.03%Open: 5,008.00High: 5,038.00Low: 4,984.00Yesterday’s Close: 5,007.00






EU drugs agency move to Amsterdam minimises likely staff losses

LONDON, Nov 20 (Reuters) - Amsterdam's success in winning the battle to host the European Medicines Agency (EMA), which is relocating from London beca
[20 Nov '17 18:11]

UPDATE 1-Britain's FTSE recoups early losses as cyclicals recover

* FTSE 100 up 0.1 pct, mid caps up 0.4 pct* Roche drug trial successes hit Shire shares* Mediclinic, Spire shares fall after takeover talks fall throu
[20 Nov '17 16:55]

Roche win boosts case for adding chemo to cancer immunotherapy

* Win tilts competitive landscape in big lung cancer market* Roche, Merck & Co main backers of chemo-combo therapy* AstraZeneca, Bristol-Myers betting
[20 Nov '17 14:20]

Britain's FTSE stuck at 7-week lows as cyclicals, Shire declines

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)*
[20 Nov '17 10:10]

UPDATE 5-Roche gets $12 bln stock boost from positive cancer, haemophilia results

* Tecentriq, Hemlibra trials meet study goals* The drugs are pillars of Roche growth strategy* Roche playing catch-up in cancer immunotherapy (Recasts
[20 Nov '17 06:59]

UPDATE 6-Roche stock up $12 bln on cancer, haemophilia trials; rivals hit

* Tecentriq, Hemlibra trials meet study goals* Two drugs are pillars of Roche growth strategy* Roche playing catch-up in cancer immunotherapy (Adds la
[20 Nov '17 06:59]

UPDATE 2-Roche announces trial successes in cancer, haemophilia

* Tecentriq, Hemlibra trials meet study goals* The drugs are pillars of Roche growth strategy* Roche playing catch-up in cancer immunotherapy (Adds de
[20 Nov '17 06:59]

UPDATE 3-Roche shares climb after trial wins in cancer, haemophilia

* Tecentriq, Hemlibra trials meet study goals* The drugs are pillars of Roche growth strategy* Roche playing catch-up in cancer immunotherapy (Adds co
[20 Nov '17 06:59]



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.